Your session is about to expire
← Back to Search
Acupuncture for Lung Cancer (POISE Trial)
Phase 3
Recruiting
Led By Dugald Seely, ND, MSc
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults eligible for complete resection of lung, gastric or esophageal cancer
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
POISE Trial Summary
This trial is studying the effect of acupuncture on quality of life for patients with thoracic cancer who are undergoing surgery.
Who is the study for?
This trial is for adults ready to undergo complete removal of lung, gastric, or esophageal cancer. It's not for those who've had minor lung surgery, seen a naturopathic doctor recently, are pregnant/breastfeeding, used experimental drugs lately, have certain tumor types or recent active cancer treatment.Check my eligibility
What is being tested?
The trial tests an integrative approach combining nutrition and physical activity guidance with psychological support and supplements like Green Tea Extract and Vitamin D3. The goal is to improve quality of life after thoracic surgery by reducing complications and the risk of cancer returning.See study design
What are the potential side effects?
Potential side effects from the supplements may include digestive issues, allergic reactions, changes in energy levels or mood disturbances. However, these interventions aim to be gentle and supportive alongside conventional care.
POISE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My lung, stomach, or esophagus cancer can be completely removed by surgery.
POISE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cross-over and contamination in the control arm - Mediterranean Diet Scores
Cross-over and contamination in the control arm - Physical Activity levels
Cross-over and contamination in the control arm - Psychological Health Activities
+3 moreSecondary outcome measures
Communication
Inflammatory Response
Natural Killer Cell Function
+2 morePOISE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Integrative Care (Treatment)Experimental Treatment10 Interventions
Participants in the Integrative arm will receive standard surgical and oncologic care at The Ottawa Hospital plus complementary care guided by a naturopathic doctor at The Centre for Health Innovation
Group II: Standard Care (Control)Active Control1 Intervention
Participants in the control arm will receive standard surgical and oncologic care at The Ottawa Hospital
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Green Tea Extract
2019
N/A
~40
Find a Location
Who is running the clinical trial?
Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,671 Total Patients Enrolled
The Canadian College of Naturopathic MedicineOTHER
22 Previous Clinical Trials
2,617 Total Patients Enrolled
Lotte & John Hecht Memorial FoundationOTHER
17 Previous Clinical Trials
4,573 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a part of my lung removed due to cancer.My cancer is not small cell, carcinoid, or GIST.My lung, stomach, or esophagus cancer can be completely removed by surgery.I haven't had cancer treatment in the last 3 years, except for superficial bladder or non-melanoma skin cancer.I am currently seeing or have seen a naturopathic doctor in the last 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: Integrative Care (Treatment)
- Group 2: Standard Care (Control)
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many people are enlisted in this experiment?
"That is correct. The listing on clinicaltrials.gov currently states that the trial is still looking for patients. The trial was originally posted on 4/4/2022 and was last updated 8 days ago on 4/8/2022. They are hoping to find 20 patients total from 1 location."
Answered by AI
Is there any evidence to support the efficacy of Probiotic Pro12?
"There is both pre-existing efficacy data as well as multiple rounds of safety data, so Probiotic Pro12 was given a score of 3 for safety."
Answered by AI
Are people still being sought for participation in this experiment?
"Yes, this clinical trial is still recruiting patients according to the information posted on clinicaltrials.gov. The study was originally advertised on 4/4/2022 and has since been edited on 4/8/2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger